A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.
Also called NCT01847092
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 154 participants
- Sponsor
- Registry
-
NCT01847092
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01847092. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-03 (actual). Results posted on 2020-05-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
- Condition
- Chronic Kidney Disease
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- AZD1722
- Intervention (Drug)
- Placebo
- Lead sponsor
- Ardelyx
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct01847092- Content hash
d0de40f6d01d07c8fc23b25c0c9937f510287a862a9954f701b18bdd3e358c37